Bloomberg Podcasts
@bloombergpodcasts·503K subscribers·32.4K videos
President Trump Signs Health Research Order With RFK Jr. In Attendance: Full White House Event
Posted
May 5, 2025
Views
4,366
Likes
97
Comments
22
Engagement
May 5, 2025
4,366
97
22
2.73%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
19:49Now PlayingPresident Donald Trump signed an executive order looking to limit federal funding for gain-of-function research that involves altering pathogens, suggesting the efforts could have been responsible for the outbreak of the Covid-19 pandemic.
“It could have been that we didn’t have the problem we had,” Trump told reporters Monday as he signed the executive order in the White House.
While the origins of the coronavirus pandemic remain unclear, some US intelligence agencies have concluded it’s likely that Covid-19 broke out from the Wuhan Institute of Virology. Scientists, including at that lab, use both breeding practices and genetic engineering to make viruses more infectious, arguing the research is valuable for vaccine studies and to better understand pathogens.
“There’s no laboratory that does this right, there’s no laboratory that’s immune from leaks,” Health Secretary Robert F. Kennedy Jr. said. “This is going to prevent these kind of inadvertent leaks from happening in the future and endangering humanity.”
The order will end US funding of gain-of-function research in countries deemed to have insufficient oversight, and allows the federal government to identify and end private biological research deemed a threat to American public health, according to the New York Post, which first reported the executive order.
The order was one of a series of health-related executive orders and proclamations Trump signed Monday. Another, which the White House did not immediately provide details of, is designed to promote domestic manufacturing of pharmaceuticals.
The president has threatened to impose additional tariffs on drugs made overseas in a bid to move drugmaking to the US, and said Monday that the announcement would come within “two weeks.”
Trump also teased another announcement related to drug prices in the coming days.
--------
Watch Bloomberg Radio LIVE on YouTube
Weekdays 7am-6pm ET
Follow us on X
Subscribe to our Podcasts:
Bloomberg Daybreak
Bloomberg Surveillance
Bloomberg Intelligence
Balance of Power
Bloomberg Businessweek
Listen on Apple CarPlay and Android Auto with the Bloomberg Business app:
Apple CarPlay
Android Auto
Visit our YouTube channels:
Bloomberg Podcasts
Bloomberg Television
Bloomberg Originals
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
